Efficacy of lignocaine analgesia during treatment to the cervix.
There is no consensus amongst physicians about the need for analgesia when a woman undergoes ablative therapy of the cervix. Many doctors believe that the discomfort felt during such procedures is insubstantial. By means of a randomised double-blind placebo-controlled trial, we have shown that patients experience considerable pain during cold-coagulation treatment of the cervix. We found that intracervical lignocaine leads to a significant (p < 0.01) reduction in this pain.
Rogstad
K E
KE
Department of Genitourinary Medicine, City Hospital, Nottingham, UK.
White
D J
DJ
Ahmed-Jushuf
I H
IH
D000698:Analgesia; D003080:Cold Temperature; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008012:Lidocaine; D010146:Pain / Q000209:etiology / Q000517:prevention & control*; D010147:Pain Measurement; D011795:Surveys and Questionnaires; D002577:Uterine Cervical Diseases / Q000628:therapy*
D008012:Lidocaine